Brind.

Swissmedic approved a new malaria medicine from Novartis on July 8, 2025.

1 report, 0 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Novartis Swissmedic

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
Swissmedic
licensing and inspection authority for remedies in Switzerland with headquarters in Bern

Nothing else this week.

Related events

Novartis sought Swissmedic regulatory approval for a drug, which was co-funded by Sida and introduced first in Ghana.Sep 15
Major pharmaceutical companies, including Novartis, Roche, AstraZeneca, and Pfizer, maintain significant presences in Switzerland.Jun 17

Coverage

Newest first; wire copies grouped

Jul 8Unknown outlet